Comment
Caspofungin was as effective as amphotericin B for invasive candidiasis
Affiliations
- PMID: 12841719
Item in Clipboard
Comment
Caspofungin was as effective as amphotericin B for invasive candidiasis
ACP J Club.
2003 Jul-Aug.
No abstract available
Comment on
-
Comparison of caspofungin and amphotericin B for invasive candidiasis.N Engl J Med. 2002 Dec 19;347(25):2020-9. doi: 10.1056/NEJMoa021585. N Engl J Med. 2002. PMID: 12490683 Clinical Trial.
Similar articles
-
Caspofungin: new indication. No progress in invasive candidiasis.Prescrire Int. 2004 Apr;13(70):48-9. Prescrire Int. 2004. PMID: 15148956
-
Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.Antimicrob Agents Chemother. 2005 Dec;49(12):4895-902. doi: 10.1128/AAC.49.12.4895-4902.2005. Antimicrob Agents Chemother. 2005. PMID: 16304150 Free PMC article.
-
Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial.Pediatr Infect Dis J. 2008 Sep;27(9):820-6. doi: 10.1097/INF.0b013e31817275e6. Pediatr Infect Dis J. 2008. PMID: 18679151 Clinical Trial.
-
Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.Clin Infect Dis. 2007 Oct 1;45(7):883-93. doi: 10.1086/520980. Epub 2007 Aug 29. Clin Infect Dis. 2007. PMID: 17806055 Clinical Trial.
-
Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis.J Antimicrob Chemother. 2007 Mar;59(3):556-9. doi: 10.1093/jac/dkl525. Epub 2007 Jan 22. J Antimicrob Chemother. 2007. PMID: 17242032